Phathom Pharmaceuticals Ownership | Who Owns Phathom Pharmaceuticals?
Phathom Pharmaceuticals Ownership Summary
Phathom Pharmaceuticals is owned by 40.51% institutional investors, 4.31% insiders, and 55.18% retail investors. Frazier life sciences management is the largest institutional shareholder, holding 17.32% of PHAT shares. Invesco OFI Global Equity is the top mutual fund, with 2.89% of its assets in Phathom Pharmaceuticals shares.
PHAT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Phathom Pharmaceuticals | 40.51% | 4.31% | 55.18% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Frazier life sciences management | 10.11M | 17.32% | $104.13M |
| Medicxi ventures management (jersey) | 7.46M | 11.55% | $60.61M |
| Jennison associates | 7.06M | 10.93% | $57.35M |
| Invesco | 3.67M | 5.68% | $29.81M |
| Blackrock funding, inc. /de | 3.50M | 5.42% | $28.44M |
| Carlyle group | 3.50M | 5.41% | $28.39M |
| Blackrock | 2.93M | 5.01% | $30.14M |
| Vanguard group | 2.78M | 4.30% | $22.57M |
| Ensign peak advisors | 2.53M | 3.91% | $20.52M |
| Checkpoint capital | 2.27M | 3.52% | $18.47M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Medicxi ventures management (jersey) | 7.46M | 11.46% | $60.61M |
| Checkpoint capital | 2.27M | 9.40% | $18.47M |
| Catalys pacific | 1.17M | 8.18% | $9.48M |
| Propel bio management | 989.93K | 7.98% | $8.04M |
| Frazier life sciences management | 10.11M | 4.87% | $104.13M |
| Stepstone group lp | 422.08K | 3.00% | $3.43M |
| Ghost tree capital | 600.00K | 1.94% | $6.18M |
| Decheng capital | 694.25K | 1.21% | $5.64M |
| Avidity partners management lp | 1.39M | 1.11% | $11.29M |
| Penn mutual asset management | 62.80K | 0.92% | $509.95K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Wasatch advisors lp | 1.56M | 0.06% | 1.31M |
| Jennison associates | 7.06M | 0.03% | 1.20M |
| Checkpoint capital | 2.27M | 9.40% | 769.85K |
| Morgan stanley | 762.60K | 0.00% | 525.44K |
| Tang capital management | 500.00K | 0.27% | 500.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Portolan capital management | - | - | -1.70M |
| Woodline partners lp | 1.00M | 0.06% | -1.57M |
| Orbimed advisors | - | - | -1.45M |
| Federated hermes | - | - | -1.40M |
| Saturn v capital management | - | - | -874.59K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tang capital management | 500.00K | 0.27% | 500.00K | $4.06M |
| Raymond james financial | 455.84K | 0.00% | 455.84K | $3.70M |
| Trexquant investment lp | 378.64K | 0.04% | 378.64K | $3.07M |
| Cubist systematic strategies | 282.55K | 0.01% | 282.55K | $2.29M |
| Qube research | 55.97K | 0.00% | 55.97K | $454.50K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Srs capital advisors | -17.00 |
| Capital performance advisors llp | -29.00 |
| Cwm | -32.00 |
| Russell investments group | -36.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 58 | -57.97% | 26,182,383 | -63.96% | 40 | 0.32% | 35 | -58.82% | 11 | -45.00% |
| Sep 30, 2024 | 138 | 18.97% | 72,638,512 | 28.44% | 112 | 1.21% | 85 | 28.79% | 20 | - |
| Jun 30, 2024 | 115 | -1.71% | 56,555,159 | 8.24% | 96 | 1.17% | 66 | 24.53% | 19 | -44.12% |
| Mar 31, 2024 | 117 | -2.50% | 52,249,167 | 11.99% | 91 | 1.35% | 53 | -28.38% | 34 | 47.83% |
| Dec 31, 2023 | 120 | 6.19% | 46,653,575 | 6.61% | 82 | 1.01% | 74 | 17.46% | 23 | -4.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Invesco OFI Global Equity | 1.98M | 2.89% | - |
| Invesco Global A | 1.98M | 2.84% | - |
| PGIM Jennison Health Sciences Z | 1.78M | 2.60% | - |
| Jennison Health Sciences Equity | 1.78M | 2.56% | - |
| Vanguard US Total Market Shares ETF | 1.65M | 2.36% | 280.90K |
| Vanguard Total Stock Mkt Idx Inv | 1.59M | 2.32% | - |
| PGIM Jennison Small Company A | 1.58M | 2.30% | - |
| Jennison SMid Cap Core Equity | 1.58M | 2.27% | - |
| Strategic Advisers U.S. Total Stock{mg} | 1.48M | 2.16% | -273.72K |
| Strategic Advisers Small-Mid Cap | 1.24M | 1.82% | 278.88K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 07, 2025 | Henderson Molly | CFO and CBO | Sell | $16.74K |
| Mar 13, 2025 | Parikh Asit | - | Buy | $44.20K |
| Jan 21, 2025 | Henderson Molly | CFO and CBO | Sell | $43.37K |
| Jan 21, 2025 | Nabulsi Azmi | Chief Operating Officer | Sell | $51.96K |
| Jan 21, 2025 | Curran Terrie | President and Chief Executive | Sell | $125.88K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | 1 | 3 |
| 2024 Q4 | 2 | 2 |
| 2024 Q3 | - | 3 |
| 2024 Q2 | - | 1 |
PHAT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools